The VCU Massey Comprehensive Cancer Center completed the inaugural funding cycle of its VCU–Sanford Burnham Prebys Drug Discovery Collaborative Program, a collaboration with the Sanford Burnham Prebys Medical Discovery Institute in La Jolla, CA.
A research team led by investigators at Virginia Commonwealth University found evidence suggesting there is a positive association between GLP-1 agonists—drugs commonly used to treat obesity and diabetes—and better outcomes among breast cancer patients.
